For technology companies, especially monopoly technology companies, fines are nothing more than passing costs on to consumers.
When making internal budgets, fines will be estimated in advance.
The most fearful thing is that the market is blocked and you are completely prevented from entering the market.
They want to nurture their own businesses.
This is unacceptable to monopolistic companies.
Li Miaomiao: "The commercial department of the Europa Union has approached us and hopes that Kechuang Biotech will increase its investment in the Europa Union."
"Because our current investment in the Europa continent is mainly in England, and there is very little investment in other parts of Europe."
Li Shuyao: "This is your internal strategic plan. Why should the Europa Union interfere?"
"The languages of the Europa League are not unified. But this market is very important for console games."
"It's very contradictory, but if the Europa Union bans brain-computer connected VR from entering its market, it won't be just you who should be anxious, Goose Factory will be even more anxious."
"I heard from colleagues that VR is regarded as a new strategic direction within Goose Factory."
"I would like to ask if Kechuang will be listed in the future? CICC leaders are already asking about it. If it goes public, CICC can help you with the underwriting."
CICC’s senior management knew exactly what the connections were behind each person.
Li Shuyao's greatest value is not her academic qualifications or her appearance, but that she is Li Miaomiao's sister and can get first-hand information about science and technology.
Therefore, being able to enter CICC is a blessing and a tragedy for Li Shuyao.
However, in Li Shuyao's view, this is just a small matter and will not affect her mentality.
To be honest, if I can't resist the pressure, there is no need to be involved in the financial circle.
Another benefit of being backed by Science and Technology Biotechnology is that she only needs to do the essential work and get some information when the time is right.
Li Miaomiao thought for a while and then said: "If we want to design VR chips, we may need financing."
"But I talked to the executives of Goose Factory and Rice about this matter, and they all said they were not in a hurry to go public."
"If Kechuang does not have enough liquidity in the future, everyone will inject capital in proportion."
"So we have no internal consensus on whether it will be listed."
Kechuang's future brain-computer connection VR chips still need to be imported. The only self-produced products are brain-computer connection chips and AI computing chips.
Li Shuyao: "If we want to develop self-developed chips, the investment will be huge, and the output may not be achieved."
"It took many years to raise HiSilicon before it finally came to fruition. The earliest HiSilicon chips were used in OEM machines."
"It's not an easy decision to make, but eating from the lower reaches of the industrial chain to the upper reaches is also a breakthrough route."
"Kechuang Biotechnology's annual profits can afford to support a chip design team, and you can even cooperate with SMIC."
"SMIC's 7nm chip is said to be tape-out next year."
Li Miaomiao: "It is said that I just heard that the technology of Huaweigan's biological storage server was obtained from Merlin."
Li Shuyao was shocked: "Where did you get the news? I've never heard of it, and wasn't the biological storage technology developed by Deep Blue Storage?"
"We went to Deep Blue Storage for research, and all the R&D personnel there were transferred directly from the Chinese Academy of Sciences."
"Shuguang, Inspur, and Ziguang all want to build their own biological storage servers. It is said that they are all waiting for Deep Blue Storage to release production capacity."
"But if the biological storage technology is provided by Merlin, then has our country reached some kind of cooperative relationship with Merlin?"
"No wonder domestic semiconductor stocks have been falling all the way during this period. I want to clear out my semiconductor ETF!" Li Shuyao suddenly realized.
CICC employees cannot buy and sell stocks in Big A, but they can buy ETFs.
Li Miaomiao sighed: "This is just a rumor in the market and has not been confirmed at the official level."
"But a very important point is that if Merlin provides biological storage technology, then he most likely has biological computer technology in his hands."
"When the biocomputer is launched, it will be a dimensionality-reducing blow to semiconductors."
"To invest in chip design now, the unknown risk is too great."
Li Shuyao analyzed: "Even if biocomputer technology is available, the replacement of silicon-based computer technology will still require a process."
"It will certainly not be the case that all of them will be suddenly replaced by biological computers one day. During the gradual replacement process, silicon-based computers and biological computers will reach a certain balance."
"I think it is possible to invest. Industrial integration is a major trend. It is better to do it early than to do it late."
“Make risk control calculations before investing.”
Li Miaomiao sighed: "It's a lot of pressure. I feel like there's nothing else but work every day."
"There is no incremental business anymore at work. If you want to do incremental business, you need to consider many factors. I am very afraid that the incremental business will fail."
"I'm just afraid that if I make a mistake on my errand, I'll injure my muscles and bones."
Li Shuyao shouted: "You are a bit Versailles. The current size of Science and Technology Biotech and the technical barriers you have built can make you make strategic mistakes more than twice."
"You are a technology monopoly, unlike Goose Factory, which relies on the moat built by the number of users."
"The company you benchmark against in history should be IBM. Back then, IBM missed the wave of personal PCs and the mobile Internet. Isn't it still living a good life now?"
IBM, the blue giant, has a history of more than a hundred years and is still ranked in the top 50 of the Fortune 500 in 2024.
"You should learn from IBM and encourage internal patent innovation and application. More patents will always come in handy."
Li Miaomiao: "If Kechuang Biotech can live this long, I will be satisfied."
“Investing in internal research and development requires money and people who can afford it.”
“Currently, Kechuang Biotech’s main sources of profit are the patent licensing of brain-computer connection to mobile phones and the patent licensing of endorphins.”
"It still depends on how effective the brain-computer connection to VR is this time."
...
Station B has had a hard time in the past few years. Its stock price has halved from its high point, and it even has to return to the Hong Kong stock market from Nasdaq to relist.
Secondly, the launch of pre-roll ads was boycotted by users, and the number of major members paying has been declining year after year.
Later, the pre-title advertisement was removed, but it did not restore the reputation of users.
It's okay to have sex for free, but if you want me to top up the money, forget it.
The decline in income of up owners has led to a decline in video quality.
The strategic transformation cannot find a direction, and it is not an exaggeration to describe it as a failure.
As a domestic first-line content and entertainment platform, Station B has naturally obtained a brain-computer connection VR sample from Kechuang Future.
After using it, they have new ideas.
“Brain-computer connected VR can definitely become an important part of our future.
We can do vr video and vr live broadcast. "
"There are VR videos on site B, but the problem is that they are not popular and have not become mainstream. How can you be sure that a brain-computer connected VR video will become popular?"
